In esercizioSaluteTesto originale in inglese
FDA approves Rasonque for advanced pancreatic cancer
The drug nearly doubled median overall survival in a second-line clinical trial.
Scritto dall’IA3 fonti2 min
Loading…
Diagnosi, protesi, vaccini, genomica: la medicina che guadagna anni di vita.
The drug nearly doubled median overall survival in a second-line clinical trial.
- Johnson & Johnson’s Imaavy is cleared for patients aged 12 and older with warm autoimmune hemolytic anemia.
The test is for people with cognitive symptoms, not general health screening.
Regeneron’s drug targets FOP, which progressively locks patients’ limbs by causing bone to form in soft tissue.
Vitestro’s Aletta can handle a blood draw while one trained phlebotomist oversees up to three devices.
A clinical trial found chilled platelets worked as well as room-temperature units for up to 21 days.
Eve lets eligible wheelchair users with spinal cord injuries walk hands-free.